Research Article
High Expression of COL17A1 Predicts Poor Prognosis and Promotes the Tumor Progression via NF-κB Pathway in Pancreatic Adenocarcinoma
Table 1
Clinicopathologic characteristics of 169 PDAC patients.
| Patients characteristics | Number of cases (%) |
| Age (years) | ≤60 | 76 (45.0) | >60 | 93 (55.0) |
| Gender | Male | 96 (56.8) | Female | 73 (43.2) |
| Clinical stage | I or II | 95 (56.2) | III or IV | 74 (43.8) |
| T classification | T1 or T2 | 38 (22.5) | T3 or T4 | 131 (77.5) |
| N classification | N0 | 98 (58.0) | N1-2 | 71 (42.0) |
| Metastasis | No | 163 (96.4) | Yes | 6 (3.6) |
| Pathologic differentiation | High (middle or high) | 115 (68.0) | Low (No or low) | 54 (32.0) |
| Vascular invasion | No | 119 (70.4) | Yes | 50 (29.6) |
| Neural invasion | No | 87 (51.5) | Yes | 82 (48.5) |
| Vital states(at follow-up) | Alive | 70 (41.4) | Dead | 99 (58.6) |
| Expression of COL17A1 | Low expression | 63 (37.3) | High expression | 106 (62.7) |
|
|